UCSF is working to create an online platform that health workers around the world can use to predict where malaria is likely to be transmitted using data on Google Earth Engine.
September 10, 2014
August 27, 2014
Children who repeatedly become infected with malaria often experience no clinical symptoms with these subsequent infections, and a team led by UC San Francisco researchers has discovered that this might be due at least in part to a depletion of specific types of immune cells.
July 31, 2014
All over the world, men die younger than women and do worse on a host of health indicators, yet policy makers rarely focus on this “men’s health gap” or adopt programs aimed at addressing it, according to an international group of researchers and health charity workers.
May 22, 2014
Researchers at UCSF, UC Berkeley and partner institutions are receiving $6 million to help address three neglected tropical diseases that place a huge health and economic burden on people in Central and South America: Chagas’ disease, dengue and onchocerciasis.
May 15, 2014
Harvey V. Fineberg, MD, PhD, MPP, the President of the Institute of Medicine, will come to UCSF for a yearlong appointment as a Presidential Chair beginning in September.
April 25, 2014
A renowned molecular biologist and an internationally acclaimed global health leader from UC San Francisco have been elected as members of the American Academy of Arts and Sciences.
April 24, 2014
As we mark World Malaria Day this year, UCSF’s Global Health Group is celebrating the success of Namibia, where malaria case have dropped 98 percent over the past decade.
April 10, 2014
UCSF bestowed its highest honor, the UCSF Medal, this year to Carrol Estes, Richard Rosenberg, Martha Ryan and Pablo Valenzuela.
December 18, 2013
Research led by scientists at the UCSF-affiliated Gladstone Institutes has identified the precise chain of molecular events in the human body that drives the death of most of the immune system’s CD4 T cells as an HIV infection leads to AIDS. Further, they have identified an existing anti-inflammatory drug that in laboratory tests blocks the death of these cells.
December 18, 2013
A new study provides further proof that regular use of the the HIV antiretroviral drug Truvada can reduce one’s risk for contracting HIV – without increasing sexual risk behavior.